ViroStatics CEO Franco Lori, MD to Present Novel Immune-based Technologies for HIV/AIDS and Chronic Diseases at the 2011 Biotechnology Industry Organization (BIO) International Conference

SASSARI, Italy & PRINCETON, N.J.--(BUSINESS WIRE)--ViroStatics, an Italian/American biopharmaceutical company developing novel therapeutics for viral and other chronic diseases, announced today that the Company’s CEO, Franco Lori, MD, will be an invited speaker at the 2011 BIO International Convention being held this week in Washington, DC. Dr. Lori will participate in a panel discussion entitled "Looking to the Future: Innovative Approaches to HIV Vaccine Development and Immunotherapies" that will take place on Wednesday, June 29th at 10:00 am in Room 151B in the Walter E. Washington Convention Center.